Page 116 - GTM-4-1
P. 116

Global Translational Medicine                                          AA amyloidosis in rheumatoid arthritis




            Table 2. Statistical correlations (P-values) between female and male RA patients with sAAa and giAAa at different stages
            Patient cohorts with RA                                Age          Onset of RA       Duration of RA
            RA patients (n=161) versus sAAa (n=34 of 161)          0.321          0.376               0.554
             Female: n=116 of 161 versus n=29 of 34                0.800          0.631               0.682
             Male: n=45 of 161 versus n=5 of 34                    0.348          0.565               0.688
            With sAAa (n=34 of 161) versus without sAAa (n=127 of 161)  0.213     0.262               0.462
             Female: n=29 of 34 versus n=87 of 127                 0.745          0.528               0.593
             Male: n=5 of 34 versus n=40 of 127                    0.297          0.521               0.662
            With sAAa (n=34 of 161) versus with giAAa (n=31 of 34)  0.811         0.883               0.867
             Female: n=29 of 34 versus n=26 of 31                  0.623          0.820               0.861
             Male: n=5 of 34 versus n=5 of 31                      1.000          1.000               1.000
            With latent  giAAa (n=2 of 31) versus with mild giAAa (n=17 of 31)  0.364  –               –
                   a
             Female: n=2 of 2 versus n=0 of 17                     0.676            –                  –
             Male: n=0 of 2 versus n=4 of 17                        –               –                  –
            With latent* giAAa (n=2 of 31) versus with severe giAAa (n=12 of 31)  0.115  –             –
             Female: n=2 of 2 versus n=8 of 12                     0.050            –                  –
             Male: n=0 of 2 versus n=4 of 12                        –               –                  –
            With mild giAAa (n=17of 31) versus with severe giAAa (n=12 of 31)  0.363  0.127          0.560–
             Female: n=2 of 2 versus n=8 of 12                     0.048          0.436               0.030
             Male: n=0 of 2 versus n=4 of 12                        –               –                  –
            Note:  Amyloid A deposits were not found (detected) in tissue blocks of the gastrointestinal tract of two patients with sAAa, which were considered as
                a
            latent-stage giAAa.
            Abbreviations: giAAa: Gastrointestinal amyloid A amyloidosis; RA: Rheumatoid arthritis; sAAa: Systemic amyloid A amyloidosis.
            3.3. Immunohistochemical characteristics of sAAa   deposits were not observed in the brain. The most extensive
            and/or giAAa                                       deposits were found in the kidneys and heart (Table 3).
            AA deposits exhibit a positive reaction for anti-human   In 22 (64.71%) of 34 RA patients with sAAa, the average
            AA components when subjected to immunohistochemical   amount of AA deposits per patient was <0.8, which was
            staining (Figure 3). The anti-human AA reaction is highly   classified as mild. In 12 (35.29%) of 34 patients, the AA
            specific; however, minimal AA deposits may not be   deposit load  was  >0.8,  classifying  it as  severe  (Patients
            detected.                                          23 – 34 in Table 3). Table 3 and Figures 5-7 summarize
                                                               the quantitative differences in AA deposits across various
            3.4. Histochemical characteristics of sAAa and/or   organs (kidneys, heart, pancreas, GI tract, liver, lungs, skin,
            giAAa                                              and brain) in 34 RA patients with sAAa.
            AA  deposits  associated  with  sAAa  exhibit  sensitivity  to   The prevalence and amount of AA deposits in patients with
            performate pre-treatment (1 s) and variable resistance   sAAa followed a generally parallel trajectory (Table 3), aligning
            to KMnO  oxidation, depending on the exposure time:   with the trend lines of incremental increase (Figure 5), except
                    4
            (i) resistant for 30 sec – 1 min, (ii) resistant/sensitive for   during the early and terminal stages of amyloid deposition.
            3 – 5 min, and (iii) sensitive for 10 min. The histological   Figure 5 illustrates the prevalence and amount of AA deposits
            and histochemical characteristics of sAAa and/or GI AA   across eight organs in 34 RA patients with sAAa. In the early
            deposits are demonstrated using light and polarization   stage of sAAa, AA deposition started abruptly, while in the
            microscopy in Figure 4.
                                                               terminal stage, AA deposition accelerated again, resulting in
            3.5. Characteristics of sAAa                       an exponential increase in the growth curve. In some patients,
                                                               moderate differences between the prevalence and severity of
            The accumulation of AA deposits in various organs   sAAa were observed, primarily due to the unavailability of
            followed a progressive and primarily linear trajectory, with   tissue samples from certain organs.
            an abrupt onset and an exponential increase in the terminal
            stage. Amyloid deposition most frequently affected the GI   The prevalence and amount of AA deposits in various
            tract and pancreas, compared to other organs, while AA   organs of 34 RA patients with sAAa followed a generally


            Volume 4 Issue 1 (2025)                        108                              doi: 10.36922/gtm.5325
   111   112   113   114   115   116   117   118   119   120   121